DE60216242D1 - Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen - Google Patents

Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen

Info

Publication number
DE60216242D1
DE60216242D1 DE60216242T DE60216242T DE60216242D1 DE 60216242 D1 DE60216242 D1 DE 60216242D1 DE 60216242 T DE60216242 T DE 60216242T DE 60216242 T DE60216242 T DE 60216242T DE 60216242 D1 DE60216242 D1 DE 60216242D1
Authority
DE
Germany
Prior art keywords
emulsions
solution
active ingredients
hfa propellants
hfa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60216242T
Other languages
English (en)
Other versions
DE60216242T2 (de
Inventor
Brian John Meakin
David Andrew Lewis
Susan Ann Berrill
Rebecca Jayne Davies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of DE60216242D1 publication Critical patent/DE60216242D1/de
Publication of DE60216242T2 publication Critical patent/DE60216242T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
DE60216242T 2002-06-06 2002-06-06 Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen Expired - Fee Related DE60216242T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012602A EP1369113B1 (de) 2002-06-06 2002-06-06 Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen

Publications (2)

Publication Number Publication Date
DE60216242D1 true DE60216242D1 (de) 2007-01-04
DE60216242T2 DE60216242T2 (de) 2007-05-24

Family

ID=29433123

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216242T Expired - Fee Related DE60216242T2 (de) 2002-06-06 2002-06-06 Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen

Country Status (7)

Country Link
US (1) US20060165603A1 (de)
EP (2) EP1369113B1 (de)
AU (1) AU2003245905A1 (de)
CA (1) CA2488354A1 (de)
DE (1) DE60216242T2 (de)
ES (1) ES2275778T3 (de)
WO (1) WO2003103642A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
JP6267218B2 (ja) * 2012-11-06 2018-01-24 ロチャル インダストリーズ，エルエルシー 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達
AU2015217274B2 (en) 2014-02-14 2019-07-25 Mission Pharmacal Company Sprayable composition containing zinc oxide and a fluoro-olefin propellant
ES2755368T3 (es) 2014-02-14 2020-04-22 Mission Pharma Co Dispositivo de suministro por aspersión
MX2016009388A (es) 2014-02-14 2017-04-13 Mission Pharma Co Emulsion estabilizada que puede rociarse que contiene particulas de agentes activos.
WO2015200049A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
EP2985019B1 (de) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasale Zusammensetzung mit antiviralen Eigenschaften

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145604A (en) * 1990-09-19 1992-09-08 S. C. Johnson & Son, Inc. Aqueous emulsion and aerosol delivery system using same
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6544542B1 (en) * 1998-03-05 2003-04-08 Nippon Shinyaku Co., Ltd. Fat emulsions for inhalational administration
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
FR2795960B1 (fr) * 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
AU4445201A (en) * 2000-03-30 2001-10-08 Generex Pharmaceuticals Inc. Method for administering insulin to the buccal region
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
US6551578B2 (en) * 2001-02-15 2003-04-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery

Also Published As

Publication number Publication date
WO2003103642A1 (en) 2003-12-18
EP1369113A1 (de) 2003-12-10
US20060165603A1 (en) 2006-07-27
ES2275778T3 (es) 2007-06-16
DE60216242T2 (de) 2007-05-24
CA2488354A1 (en) 2003-12-18
AU2003245905A1 (en) 2003-12-22
EP1369113B1 (de) 2006-11-22
EP1509211A1 (de) 2005-03-02

Similar Documents

Publication Publication Date Title
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
NO20063171L (no) Endoparasitisidale sammensetninger for topisk anvendelse
NO20053021D0 (no) Kaldbearbeidet stal med strimmel pakke mertensitt/austenitt mikrostruktur.
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
WO2004089396A3 (en) Anti-fungal peptidomimetics
BRPI0515518A (pt) análogos de loxapina e métodos de usos dos mesmos
EA200602137A1 (ru) Гидрогелевые препараты интерферона
BRPI0516541A (pt) composição para cuidado pessoal contendo uma fase de limpeza e uma fase de benefìcio
ATE384534T1 (de) Lösung zur nagel-verwendung
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
BRPI0620431A8 (pt) uso de um poliuretano formador de película, preparação farmacêutica líquida, aplicador e emplastro contendo a referida preparação farmacêutica
DK1440148T3 (da) Keratinocytter anvendelige som biologisk aktive substanser i behandling af sår
DE50207852D1 (de) Verwendung von fettalkoholethoxylaten als penetrationsförderer
UY29046A1 (es) Derivados de n-(1h-indolil)-1h-indol-2-carboxamidas, su preparación y su uso en terapia
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
DE50306327D1 (de) Als aerosol versprühbare w/o-emulsionen
NO20075815L (no) Formuleringer og metoder for behandling av amyloidose
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
DK1469843T3 (da) Komposition til farmaceutisk eller diætetisk anvendelse til at bekæmpe hårtab
CL2003002293A1 (es) Compuestos derivados de indazol; su composicion farmaceutica; su uso en el tratamiento de hipertension ocular.
DE602004002100D1 (de) Synergistisch wirkende herbizide mischungen
DE60216242D1 (de) Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee